The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
AIA Insights Ltd
London, United Kingdom
A
1-10 Employees
-
Key takeaway
The company emphasizes that its Drug Engine platform makes AI drug discovery techniques accessible to all scientists, fostering collaboration across various disciplines. With a focus on security and ease of use, Drug Engine aims to simplify the drug design process through AI, particularly benefiting Pharma SMEs and academics.
Reference
Core business
Drug Engine | AIA Insights
Drug Discovery Alliances
Bath, United Kingdom
A
1-10 Employees
2001
Key takeaway
Drug Discovery Alliances, Inc. specializes in pharmaceutical research and development, providing access to a global network of experts and suppliers that can enhance drug discovery efforts. Their services span the entire R&D continuum, including medicinal chemistry and cGMP API manufacturing, ensuring that they stay aligned with the latest advancements in the industry.
Reference
Product
Products - Drug Discovery Alliances, Inc.
Drug Discovery Services
Glamorous AI
London, United Kingdom
A
1-10 Employees
-
Key takeaway
The company, X-Chem, utilizes advanced AI alongside DEL and medicinal chemistry to enhance small molecule drug discovery significantly. Their innovative approach positions them as leaders in the integration of AI for more effective drug development.
Reference
Core business
Artificial Intelligence For Drug Discovery | GlamorousAI | London
Artificial Intelligence For Drug Discovery | GlamorousAI | London
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Domainex
Cambridge, United Kingdom
A
11-50 Employees
2001
Key takeaway
The company provides comprehensive and tailored services throughout the drug discovery process, from protein expression and screening to the design and optimization of drug candidates. Their multidisciplinary team emphasizes innovation and high-quality results, establishing a strong reputation for success in the field.
Reference
Core business
Drug Discovery Services | Enrich Your Medicines Pipeline | Domainex
PRESCIENT ENGINEERING LIMITED
London, United Kingdom
A
1-10 Employees
-
Key takeaway
The company offers an AI-driven Drug Discovery Software that integrates the design of new chemical entities and high-throughput screening, supported by advanced computing infrastructure. This tailored solution enhances collaboration and data management, ultimately accelerating research and innovation in drug discovery.
Reference
Core business
Prescience Insilico
pharmaGPT
Woking, United Kingdom
A
1-10 Employees
2023
Key takeaway
ADRx from PharmAdvisor is an innovative online platform that leverages generative AI to enhance the screening and diagnosis of adverse drug reactions. By providing immediate insights into potential side effects, ADRx improves diagnostic efficiency and expands treatment options for healthcare professionals.
Reference
Core business
Home
Information site for PharmAdvisor services.
MOLECULAR DISCOVERY LIMITED
Hertsmere, United Kingdom
A
1-10 Employees
1984
Key takeaway
Molecular Discovery specializes in drug design and has recently released several software tools, including BioGPS 22.01 for drug-repurposing and off-target prediction, and MoKa for pKa prediction. Their products utilize the GRID force field, enhancing molecular interaction analysis to support better drug discovery decisions.
Reference
Core business
Molecular Discovery Ltd.
Oxford Drug Design
Oxford, United Kingdom
A
1-10 Employees
2001
Key takeaway
Oxford Drug Design is actively engaged in discovering new drugs with innovative approaches to address challenging diseases that have significant unmet medical needs. Their team includes experts in computational chemistry and drug development, utilizing advanced technologies like computer-aided drug discovery and topological data analysis.
Reference
Product
Technology – Oxford Drug Design
Axis Bio
Coleraine, United Kingdom
A
11-50 Employees
2013
Key takeaway
Axis Bio specializes in providing tailored preclinical solutions to enhance early drug discovery efforts, with a focus on oncology, inflammation, and respiratory diseases. Their commitment to innovation and sustainable growth positions them as a key player in accelerating drug development and discovering new medicines.
Reference
Core business
Axis Bio | Discovery Services
OPTIBRIUM LIMITED
Cambridge, United Kingdom
A
11-50 Employees
2008
Key takeaway
Optibrium offers advanced software solutions that utilize artificial intelligence to enhance the efficiency and productivity of drug discovery, particularly in small molecule design and optimization. Their innovative products and ongoing research aim to improve decision-making processes in the drug discovery workflow, making them a key player in the integration of AI technologies in this field.
Reference
Core business
Optibrium: Elegant Drug Discovery Tools & Technologies
Optibrium is at the forefront of developing innovative products that enhance the efficiency and productivity of drug discovery. Discover more!
Technologies which have been searched by others and may be interesting for you:
When researching the AI drug discovery industry in the United Kingdom, several key factors are crucial. The regulatory landscape is significant, as compliance with both UK and EU regulations is necessary, especially given the stringent requirements for drug approval and clinical trials. Understanding the challenges of integrating AI into traditional drug discovery processes is also vital, as it involves overcoming technical barriers and ensuring data quality. The UK boasts a robust ecosystem for biotech and pharmaceutical innovation, offering numerous opportunities for collaboration between academia and industry. Environmental concerns related to drug manufacturing and the sustainability of AI technologies should not be overlooked, especially in light of increasing regulatory scrutiny on environmental impacts. The competitive landscape is characterized by a mix of startups and established firms, all vying for a share in a rapidly evolving market. Additionally, the UK is positioned as a global leader in AI research, providing a strategic advantage in the international arena. Engaging with local networks, attending industry events, and keeping abreast of advancements in AI applications can provide valuable insights and foster partnerships. Overall, a thorough understanding of these aspects will aid anyone interested in navigating the AI drug discovery sector in the UK effectively.
Some interesting numbers and facts about your company results for Ai Drug Discovery
| Country with most fitting companies | United Kingdom |
| Amount of fitting manufacturers | 1204 |
| Amount of suitable service providers | 1193 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 1984 |
| Youngest suiting company | 2023 |
Some interesting questions that has been asked about the results you have just received for Ai Drug Discovery
What are related technologies to Ai Drug Discovery?
Based on our calculations related technologies to Ai Drug Discovery are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Ai Drug Discovery?
Start-Ups who are working in Ai Drug Discovery are pharmaGPT
Which industries are mostly working on Ai Drug Discovery?
The most represented industries which are working in Ai Drug Discovery are IT, Software and Services, Biotechnology, Pharmaceuticals, Other, Consulting
How does ensun find these Ai Drug Discovery Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
